Picture of Solgenics logo

SGN — Solgenics News Story

0.000.00%
gb flag iconLast trade - 00:00
UtilitiesHighly SpeculativeMicro Cap

Result of AGM

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211117:nRSQ6791Sa&default-theme=true

RNS Number : 6791S  Ncondezi Energy Limited  17 November 2021

 

News Release

 

 

Results of AGM

 

17 November 2021: Ncondezi Energy Limited ("Ncondezi" or the "Company") (AIM:
NCCL) announces that, at the Annual General Meeting ("AGM") of the Company
held today, all resolutions were duly passed on a poll.

 

 

Enquiries

For further information please visit www.ncondezienergy.com or contact:

 

 Ncondezi Energy:           Hanno Pengilly                                 +27 (0) 71 362 3566
                            Scott Mathieson, Edward Thomas, Kane Collings  +44 (0) 20 3100 2000

 Liberum Capital Limited:

NOMAD & Joint Broker

 Novum Securities Limited   Colin Rowbury                                  +44 (0) 20 7399 9427

 Joint Broker
                            Elizabeth Johnson                              +44 (0) 777 56 55 927

 Pimlico Advisory Ltd

 Investor Relations

 

 

Ncondezi is an emerging African power development company which owns 100% of
the 300MW Ncondezi Coal Power Project which is one of the most advanced power
development projects in Mozambique. The project is strategically located in
the Tete Province in northern Mozambique, a power generating hub that
distributes power across the region. The Company is targeting delivery of
first power onto the Mozambican grid by 2023 through a 25 year offtake
agreement to meet existing demand.

 

Ncondezi has also entered the captive solar and battery storage sector through
a proposed Joint Venture with GridX Africa Development, to develop, build and
operate power solutions for the African Commercial and Industrial sector.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGDKOBKKBDDCDD

Recent news on Solgenics

See all news